Nader Kameli

Assistant professor

jazan university
Country flagSaudi Arabia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Year:

2025

Year:

2025

Year:

2025

Aim: This study aimed to examine the impact of fecal water (FW) of active and remissive Crohn's disease (CD) patients on mucin degradation and epithelial barrier function. Methods: FW and bacterial membrane vesicles (MVs) were isolated from fresh fecal samples of six healthy controls (HCs) and 12 CD patients. Bacterial composition was determined by 16S rRNA gene amplicon sequencing. Results: In vitro FW-induced mucin degradation was higher in CD samples versus HC (p < 0.01), but not associated with specific bacterial genera. FW of three remissive samples decreased transepithelial electrical resistance in Caco-2 cells by 78–87% (p < 0.001). MVs did not induce barrier alterations. Conclusion: The higher mucin-degradation capacity of CD-derived FW might suggest contributions of microbial products to CD pathophysiology.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Plant cells release tiny membranous vesicles called extracellular vesicles (EVs), which are rich in lipids, proteins, nucleic acids, and pharmacologically active compounds. These plant-derived EVs (PDEVs) are safe and easily extractable and have been shown to have therapeutic effects against inflammation, cancer, bacteria, and aging. They have shown promise in preventing or treating colitis, cancer, alcoholic liver disease, and even COVID-19. PDEVs can also be used as natural carriers for small-molecule drugs and nucleic acids through various administration routes such as oral, transdermal, or injection. The unique advantages of PDEVs make them highly competitive in clinical applications and preventive healthcare products in the future. This review covers the latest methods for isolating and characterizing PDEVs, their applications in disease prevention and treatment, and their potential as a new drug carrier, with special attention to their commercial viability and toxicological profile, as the future of nanomedicine therapeutics. This review champions the formation of a new task force specializing in PDEVs to address a global need for rigor and standardization in PDEV research.

Year:

2023

Year:

2023

Collaborators (14)

Ahmed Abdulhaq

Profosor

jazan university

SAUDI ARABIA
View details

Elham Alsahafi

-

SAUDI ARABIA
View details

Majid A Darraj

Associate Professor

jazan university

SAUDI ARABIA
View details

Yasir Mohamed Riza

-

SAUDI ARABIA
View details

Edrous Alamer

ASSOCIATE PROFESSOR

jazan university

SAUDI ARABIA
View details

Abdullah Algaissi

jazan university

SAUDI ARABIA
View details

Daisy MAE Jonkers

Professor

Maastricht University Medical Centre

NETHERLANDS
View details

Abdulaziz H. Alhazmi

jazan university

SAUDI ARABIA
View details

John Penders

Associate professor

University of Maastricht

NETHERLANDS
View details

Faisal Alzahrani

Full Professor

king abdulaziz university

SAUDI ARABIA
View details

Mohammad Imran Khan

Senior Scientist

-

SAUDI ARABIA
View details

Faisal Madkhali

Assistant Professor

jazan university

SAUDI ARABIA
View details

Ahmed Abdal Dayem

Professor

-

SOUTH KOREA
View details

Nizar A Khamjan

Associate Professor

jazan university

SAUDI ARABIA
View details